Lawrence B. Cohen

Dr. Lawrence B. Cohen

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2015 in Biomolecules
Verified
Journal Article
Open access
PDF file
MNManuela Neuman
Manuela Neuman
YMYaakov Maor
Yaakov Maor
RNRadu M. Nanau
Radu M. Nanau
EMEhud Melzer
Ehud Melzer
HMHaim Mell
Haim Mell
Stephen David Howard MalnickStephen David Howard Malnick
Stephen David Howard Malnick
The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical and translational research. It focuses on the role of the immune system and the signaling pathways of cytokines in the pathogenesis of ALD. An additional factor that contributes to the pathogenesis of ALD is lipopolysaccharide (LPS), which plays a central role in the induction of steatosis, inflammation, and fibrosis in the liver. LPS derived from the intestinal microbiota enters the portal circulation, and is recognized by macrophages (Kupffer cells) and hepatocytes. In individuals with ALD, excessive levels of LPS in the liver affect immune, parenchymal, and non-immune cells, which in turn release various inflammatory cytokines and recruit neutrophils and other inflammatory cells. In this review, we elucidate the mechanisms by which alcohol contributes to the activation of Kupffer cells and the inflammatory cascade. The role of the stellate cells in fibrogenesis is also discussed.

1 April 2016 in Current Oncology
Verified
Journal Article
Open access
LCLawrence B. Cohen
Lawrence B. Cohen
JHJ. Hamer
J. Hamer
CHC. Helwig
C. Helwig
KFKaren D Fergus
Karen D Fergus
AKA. Kiss
A. Kiss
EWEllen Warner
Ellen Warner
Purpose: The aim of the present study was to assess patient satisfaction with PYNK: Breast Cancer Program for Young Women so as to determine how the program might be improved and to provide feedback to donors. Methods: All PYNK patients who had consented to have their information entered in our database and who supplied us with their e-mail address were invited to complete a 58-item online questionnaire consisting of multiple choice and open-ended questions. Domains included demographics, provision of written and spoken information, support, infertility risk, research awareness, attitudes toward discharge, and general feedback. Results: Of 120 PYNK patients approached, 61 (51%) participated. More than 90% were satisfied or very satisfied with the timing, usefulness, and clarity of spoken and written information given, and 69% found the service and support provided by the nurse navigator to be the most helpful component of the program. Of those who had received systemic therapy, 93% recalled a health care provider initiating a discussion of the risk of treatment-related infertility, and 67% were referred to a fertility clinic. On the negative side, 11%–27% were unaware of various services provided by pynk, and 11% were unaware of PYNK’s ongoing research. One third of patients were unhappy or ambivalent about the prospect of discharge from the program. Conclusions: Patient satisfaction with this novel program for young women with breast cancer is high. This study highlights the critical role that the nurse navigator plays in patient support and dissemination of information. In contrast to other reported surveys of young cancer patients, PYNK patients are routinely given the opportunity to undergo fertility preservation.

1 May 2013 in Translational Research
Verified
Journal Article
Closed access
MNManuela Neuman
Manuela Neuman
KMKristi K. McKinney
Kristi K. McKinney
RNRadu M. Nanau
Radu M. Nanau
VKVincent Kong
Vincent Kong
IMIzabella Malkiewicz
Izabella Malkiewicz
LCLawrence B. Cohen
Lawrence B. Cohen

18 March 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
MNManuela Neuman
Manuela Neuman
Helmut K. SeitzHelmut K. Seitz
Helmut K. Seitz
SFSamuel W. French
Samuel W. French
SMStephen Malnick
Stephen Malnick
HTHeidekazu Tsukamoto
Heidekazu Tsukamoto
Manuela NeumanManuela Neuman
Manuela Neuman
The following review article presents clinical and experimental features of alcohol-induced liver disease (ALD). Basic aspects of alcohol metabolism leading to the development of liver hepatotoxicity are discussed. ALD includes fatty liver, acute alcoholic hepatitis with or without liver failure, alcoholic steatohepatitis (ASH) leading to fibrosis and cirrhosis, and hepatocellular cancer (HCC). ALD is fully attributable to alcohol consumption. However, only 10–20% of heavy drinkers (persons consuming more than 40 g of ethanol/day) develop clinical ALD. Moreover, there is a link between behaviour and environmental factors that determine the amount of alcohol misuse and their liver disease. The range of clinical presentation varies from reversible alcoholic hepatic steatosis to cirrhosis, hepatic failure, and hepatocellular carcinoma. We aimed to (1) describe the clinico-pathology of ALD, (2) examine the role of immune responses in the development of alcoholic hepatitis (ASH), (3) propose diagnostic markers of ASH, (4) analyze the experimental models of ALD, (5) study the role of alcohol in changing the microbiota, and (6) articulate how findings in the liver and/or intestine influence the brain (and/or vice versa) on ASH; (7) identify pathways in alcohol-induced organ damage and (8) to target new innovative experimental concepts modeling the experimental approaches. The present review includes evidence recognizing the key toxic role of alcohol in ALD severity. Cytochrome p450 CYP2E1 activation may change the severity of ASH. The microbiota is a key element in immune responses, being an inducer of proinflammatory T helper 17 cells and regulatory T cells in the intestine. Alcohol consumption changes the intestinal microbiota and influences liver steatosis and liver inflammation. Knowing how to exploit the microbiome to modulate the immune system might lead to a new form of personalized medicine in ALF and ASH.

Verified
Journal Article
Open access
PDF file
MNManuela Neuman
Manuela Neuman
Helmut K. SeitzHelmut K. Seitz
Helmut K. Seitz
Rolf TeschkeRolf Teschke
Rolf Teschke
Stephen David Howard MalnickStephen David Howard Malnick
Stephen David Howard Malnick
KJKamisha L. Johnson-Davis
Kamisha L. Johnson-Davis
Manuela NeumanManuela Neuman
Manuela Neuman
Hepatic cells are sensitive to internal and external signals. Ethanol is one of the oldest and most widely used drugs in the world. The focus on the mechanistic engine of the alcohol-induced injury has been in the liver, which is responsible for the pathways of alcohol metabolism. Ethanol undergoes a phase I type of reaction, mainly catalyzed by the cytoplasmic enzyme, alcohol dehydrogenase (ADH), and by the microsomal ethanol-oxidizing system (MEOS). Reactive oxygen species (ROS) generated by cytochrome (CYP) 2E1 activity and MEOS contribute to ethanol-induced toxicity. We aimed to: (1) Describe the cellular, pathophysiological and clinical effects of alcohol misuse on the liver; (2) Select the biomarkers and analytical methods utilized by the clinical laboratory to assess alcohol exposure; (3) Provide therapeutic ideas to prevent/reduce alcohol-induced liver injury; (4) Provide up-to-date knowledge regarding the Corona virus and its affect on the liver; (5) Link rare diseases with alcohol consumption. The current review contributes to risk identification of patients with alcoholic, as well as non-alcoholic, liver disease and metabolic syndrome. Additional prevalence of ethnic, genetic, and viral vulnerabilities are presented.

1 October 2008 in Gastrointestinal Endoscopy Clinics of North America
Verified
Journal Article
Closed access
MVMaya Voynarovska
Maya Voynarovska
LCLawrence B. Cohen
Lawrence B. Cohen